Cartesian Therapeutics
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Cartesian Therapeutics
RECRUITINGPhase 3NCT06799247
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis
The AURORA Study is evaluating the safety, tolerability, and efficacy of an investigational mRNA CAR T-cell therapy known as Descartes-08 in adults with acetylcholine receptor...
Sponsor: Cartesian TherapeuticsEnrolling: 10020 locations
Myasthaenia Gravis
RECRUITINGPhase 1 / Phase 2NCT07089121
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Safety, tolerability and efficacy of Descarte-08 in children, adolescents and young adults with childhood-onset systemic lupus erythematosus, ANCA-associated vasculitis, juvenile...
Sponsor: Cartesian TherapeuticsEnrolling: 502 locations
Childhood-onset Systemic Lupus ErythematousANCA-Associated Vasculitis (AAV)Juvenile Myasthenia Gravis+1